Current Medicinal Chemistry

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs
pp. 4270-4290(21)
Authors: Salerno, S.; Da Settimo, F.; Taliani, S.; Simorini, F.; La Motta, C.; Fornaciari, G.; M. Marini, A.

Novel Agents in the Management of Lung Cancer
pp. 4291-4325(35)
Authors: Kennedy, B.; Gargoum, F.; Bystricky, B.; R. Curran, D.; M. O'Connor, T.

PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
pp. 4326-4341(16)
Authors: Wu, P.; Hu, Y.-Z.

Intramolecular Cyclisation of β-Aryl-β-Amino Acids in the Design of Novel Heterocyclic Systems with Therapeutic Interest: An Unfailing Source of Diversity
pp. 4342-4369(28)
Authors: Rochais, Christophe; Rault, Sylvain; Dallemagne, Patrick

UPA and PAI-1 Analysis from Fixed Tissues - New Perspectives for a Known Set of Predictive Markers
pp. 4370-4377(8)
Authors: Malinowsky, K.; Bollner, C.; Hipp, S.; Berg, D.; Schmitt, M.; F. Becker, K.

Neurochemistry Changes Associated with Mutations in Familial Parkinson's Disease
pp. 4378-4391(14)
Authors: M. Siddique, M.; K. Tan, E.

Targeting Transcription Factor Activity as a Strategy to Inhibit Pro- Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds
pp. 4392-4404(13)
Authors: Cabrini, G.; Bezzerri, V.; Mancini, I.; Nicolis, E.; C. Dechecchi, M.; Tamanini, A.; Lampronti, I.; Piccagli, L.; Bianchi, N.; Borgatti, M.; Gambari, R.

Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review
pp. 4405-4423(19)
Authors: R. Kokil, Ganesh; V. Rewatkar, Prarthana; Verma, Arunima; Thareja, Suresh; R. Naik, Suresh

Micro-Determination of Iron in Pharmaceutical Preparations by Image Scanning and Computational Quantification
pp. 4424-4426(3)
Authors: Anwar, J.; Salman, M.; Shafique, U.; Waheed-uz-Zaman; Dar, A.; M. Anzano, J.